LAMP1 and HIV infectious disease: During acute HIV infection treatment with IFNα2 resulted in increased frequencies of CD8+ T cells expressing cytotoxic molecules like CD107a and Granzyme B, and IFNα14 preferentially targeted NK cell responses by increasing TRAIL expression (2).